Cancer Treatment Drugs Markets in China (12 Full Research Reports Collection)

  • January 2014
  • -
  • Asia Market Information & Development Company
  • -
  • 2438 pages

China's demand for cancer treatment drugs markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow.

This is a collection of 12 full market research reports:

821 Lung Cancer Treatment Drugs Markets in China
822 Breast Cancer Treatment Drugs Markets in China
823 Prostate Cancer Treatment Drugs Markets in China
824 Leukemia Treatment Drugs Markets in China
826 Ovarian Cancer Treatment Drugs Markets in China
827 Colon Cancer Treatment Drugs Markets in China
828 Cervical Cancer Treatment Drugs Markets in China
829 Brain Cancer Treatment Drugs Markets in China
830 Bladder Cancer Treatment Drugs Markets in China
843 Liver Cancer Treatment Drugs Markets in China
844 Kidney Cancer Treatment Drugs Markets in China
845 Skin Cancer Treatment Drugs Markets in China

These new studies examine China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.

Table Of Contents

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, ...

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most ...

Multiple Sclerosis (MS) Drugs and Biologics : Technologies and Global Markets

Multiple Sclerosis (MS) Drugs and Biologics : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research study offers an overview of the multiple sclerosis (MS) disease-modifying product market, including regulatory issues accompanied by detailed analyses and forecasts by product. Its main ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.